The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results from OCEAN II: A phase II study of encorafenib + binimetinib combination in Chinese patients with BRAFV600E mutated metastatic non-small cell lung cancer.
 
Huaqiang Zhou
No Relationships to Disclose
 
Qing Zhou
Honoraria - AstraZeneca; BeOne Medicines; Boehringer Ingelheim; Bristol Myers Squibb Foundation; Hengrui Medicine; Lilly; MSD; Pfizer; Roche
 
Qisen Guo
No Relationships to Disclose
 
Wei Guo
No Relationships to Disclose
 
Gongyan Chen
No Relationships to Disclose
 
Zhe Liu
No Relationships to Disclose
 
Yun Fan
No Relationships to Disclose
 
Yan Li
No Relationships to Disclose
 
Yuh-Min Chen
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol Myers Squibb Foundation; Daiichi Sankyo; GlaxoSmithKline; Janssen; Merck Sharp & Dohm; Pfizer; Roche
 
Isabelle Klauck
Employment - Pierre Fabre
Stock and Other Ownership Interests - Bristol Myers Squibb Foundation
 
Angela Guo
Employment - Pierre FFabre Laboratories
 
Benoit Sansas
Employment - Pierre Fabre
Stock and Other Ownership Interests - Pierre Fabre
Research Funding - Pierre Fabre (Inst)
 
Li Zhang
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Akeso Biopharma; AstraZeneca; CHINA SHIYAO PHARMA; HenRui; Roche; Sichuan Biokin Pharmaceutical
Research Funding - Akeso Biopharma (Inst); AstraZeneca (Inst); BMS (Inst); Chia Tai Tianqing Pharmaceutical Group (Inst); QiLu Pharmaceutical (Inst); Sichuan Biokin Pharmaceutical, (Inst); Sichuan Kelun-Biotech Biopharmaceutical (Inst)